- Abstract:
-
This review highlights recent progress in the development of anticancer radiopharmaceuticals. Molecularly targeted radiotherapy refers to the selective delivery of radionuclides that emit charged particles, such as α particles, β or Auger electrons, to cancer cells via a targeting vector. The discovery of new molecular targets through systems biology and other approaches has widened the scope for radiopharmaceutical development. Innovations in antibody engineering and humanisation, recombinan...
Expand abstract - Publication status:
- Published
- Journal:
- Clinical oncology (Royal College of Radiologists (Great Britain))
- Volume:
- 25
- Issue:
- 10
- Pages:
- 604-609
- Publication date:
- 2013-10-05
- DOI:
- EISSN:
-
1433-2981
- ISSN:
-
0936-6555
- URN:
-
uuid:22d99eb6-1f98-44e9-a51e-7f4f9c9518f5
- Source identifiers:
-
414755
- Local pid:
- pubs:414755
- Language:
- English
- Keywords:
- Copyright date:
- 2013
Journal article
Advances in anticancer radiopharmaceuticals.
Actions
Authors
Bibliographic Details
Item Description
Terms of use
Metrics
Altmetrics
Dimensions
If you are the owner of this record, you can report an update to it here: Report update to this record